Your browser is no longer supported. Please, upgrade your browser.
DVAX [NASD]
Dynavax Technologies Corporation
Index- P/E- EPS (ttm)-0.34 Insider Own0.10% Shs Outstand116.90M Perf Week-19.30%
Market Cap1.61B Forward P/E7.73 EPS next Y1.70 Insider Trans-97.40% Shs Float105.98M Perf Month-37.11%
Income-38.50M PEG- EPS next Q-0.11 Inst Own81.10% Short Float14.36% Perf Quarter-25.51%
Sales263.90M P/S6.09 EPS this Y65.50% Inst Trans7.06% Short Ratio4.13 Perf Half Y46.99%
Book/sh0.58 P/B22.71 EPS next Y308.39% ROA-6.40% Target Price25.00 Perf Year154.74%
Cash/sh3.40 P/C3.88 EPS next 5Y- ROE-49.80% 52W Range4.36 - 21.39 Perf YTD195.96%
Dividend- P/FCF8.36 EPS past 5Y25.50% ROI-28.70% 52W High-38.43% Beta1.34
Dividend %- Quick Ratio1.50 Sales past 5Y63.00% Gross Margin60.70% 52W Low202.06% ATR1.16
Employees245 Current Ratio1.60 Sales Q/Q708.20% Oper. Margin13.90% RSI (14)26.02 Volatility8.08% 6.95%
OptionableYes Debt/Eq3.26 EPS Q/Q-718.80% Profit Margin-14.60% Rel Volume1.18 Prev Close14.70
ShortableNo LT Debt/Eq3.26 EarningsNov 04 AMC Payout- Avg Volume3.68M Price13.17
Recom1.80 SMA20-20.08% SMA50-25.76% SMA2006.69% Volume4,356,155 Change-10.41%
Aug-06-21Initiated Goldman Buy $19
Aug-07-20Reiterated H.C. Wainwright Buy $14 → $12
Aug-03-20Reiterated H.C. Wainwright Buy $12 → $14
Jun-15-20Initiated Evercore ISI Outperform $14
Oct-18-19Initiated H.C. Wainwright Buy $13
Jul-11-19Upgrade Cantor Fitzgerald Neutral → Overweight $20
Feb-27-19Reiterated Cantor Fitzgerald Overweight $32 → $28
May-10-18Upgrade JP Morgan Neutral → Overweight
Mar-08-18Reiterated Cantor Fitzgerald Overweight $25 → $27
Feb-14-18Downgrade JP Morgan Overweight → Neutral
Sep-25-17Reiterated RBC Capital Mkts Outperform $26 → $28
Sep-15-17Initiated Cantor Fitzgerald Overweight $24
Jul-31-17Upgrade RBC Capital Mkts Sector Perform → Outperform $7 → $26
Jul-31-17Upgrade JP Morgan Neutral → Overweight
May-09-17Reiterated RBC Capital Mkts Sector Perform $6 → $7
Apr-28-16Downgrade RBC Capital Mkts Outperform → Sector Perform $48 → $17
Apr-27-16Downgrade JP Morgan Overweight → Neutral
Nov-30-15Initiated RBC Capital Mkts Outperform $48
Nov-25-13Upgrade MLV & Co Hold → Buy $1.50 → $5
Feb-25-13Downgrade MLV & Co Buy → Hold
Dec-03-21 04:15PM  
11:34AM  
Dec-02-21 04:05PM  
Nov-18-21 04:10PM  
Nov-12-21 07:54AM  
Nov-10-21 12:22PM  
Nov-05-21 12:16PM  
12:01PM  
Nov-04-21 06:35PM  
04:02PM  
Nov-02-21 04:10PM  
Oct-30-21 10:04AM  
Oct-29-21 08:01AM  
Oct-28-21 03:06PM  
Oct-27-21 01:46PM  
06:36AM  
Oct-21-21 04:20PM  
08:00AM  
Oct-18-21 05:43PM  
01:49PM  
02:27AM  
Oct-06-21 11:31AM  
Oct-05-21 09:17AM  
Oct-04-21 08:00AM  
Oct-01-21 06:13PM  
11:27AM  
Sep-27-21 04:15PM  
11:39AM  
Sep-25-21 05:55AM  
Sep-24-21 03:45AM  
Sep-23-21 10:34AM  
Sep-22-21 12:42PM  
09:36AM  
07:05AM  
Sep-18-21 07:03AM  
Sep-16-21 04:31PM  
Sep-15-21 07:27AM  
Sep-14-21 12:51PM  
Sep-13-21 11:22AM  
10:09AM  
08:32AM  
02:30AM  
Sep-09-21 04:02PM  
Sep-07-21 10:05AM  
Sep-02-21 04:02PM  
Aug-30-21 10:00AM  
Aug-27-21 06:01AM  
Aug-24-21 11:49AM  
Aug-23-21 04:22PM  
11:49AM  
08:00AM  
06:35AM  
Aug-20-21 06:04AM  
Aug-13-21 06:01AM  
Aug-10-21 01:28AM  
Aug-06-21 05:58AM  
Aug-04-21 06:05PM  
04:02PM  
Aug-03-21 04:10PM  
Jul-29-21 12:51PM  
Jul-28-21 03:04PM  
Jul-21-21 04:02PM  
Jul-20-21 02:51AM  
Jul-06-21 08:00AM  
Jul-02-21 04:05PM  
06:01AM  
Jun-30-21 11:04AM  
07:00AM  
04:00AM  
Jun-29-21 04:05PM  
Jun-15-21 11:50AM  
Jun-14-21 03:06AM  
Jun-09-21 04:05PM  
Jun-03-21 03:32PM  
May-27-21 11:49AM  
07:00AM  
May-19-21 04:05PM  
07:09AM  
May-11-21 12:08PM  
07:30AM  
May-10-21 12:18PM  
07:09AM  
May-09-21 03:40AM  
May-07-21 09:31PM  
06:02AM  
May-06-21 06:50PM  
04:02PM  
02:45PM  
May-04-21 04:01PM  
May-03-21 02:56AM  
Apr-29-21 05:00PM  
Apr-27-21 08:00AM  
Apr-22-21 04:05PM  
Apr-21-21 04:01PM  
Apr-19-21 04:10PM  
Apr-15-21 04:12PM  
Apr-09-21 07:06AM  
Apr-07-21 04:34PM  
03:13PM  
09:34AM  
Dynavax Technologies Corporation, a biopharmaceutical company, focuses on developing and commercializing novel vaccines in the United States. The company markets HEPLISAV-B, a hepatitis B vaccine for prevention of infection caused by all known subtypes of hepatitis B virus in age 18 years and older in the United States and Europe. It also manufactures and sells CpG 1018, the adjuvant used in HEPLISAV-B. Dynavax Technologies Corporation has a collaboration agreement with Valneva Scotland Limited; agreement with Serum Institute of India Pvt. Ltd.; and sublicense agreement with Merck, Sharp & Dohme Corp. The company was formerly known as Double Helix Corporation and changed its name to Dynavax Technologies Corporation in September 1996. Dynavax Technologies Corporation was incorporated in 1996 and is headquartered in Emeryville, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Janssen RobertSenior Vice PresidentNov 17Option Exercise10.4753,431559,42361,707Nov 18 05:06 PM
Janssen RobertSenior Vice PresidentNov 17Sale17.0753,431912,2928,276Nov 18 05:06 PM
Janssen RobertSenior Vice PresidentNov 16Option Exercise10.4735,974376,64844,250Nov 18 05:06 PM
Janssen RobertSenior Vice PresidentNov 16Sale17.1635,974617,4798,276Nov 18 05:06 PM
Novack David FPresident & COONov 01Sale20.1220,000402,40044,066Nov 02 05:30 PM
Novack David FPresident & COOOct 07Sale18.003,00054,00064,066Oct 08 05:59 PM
Novack David FPresident & COOOct 01Sale18.2317,000309,84467,066Oct 05 07:04 PM
Janssen RobertSenior Vice PresidentSep 01Option Exercise10.479009,4239,176Sep 03 05:00 PM
Burgess JustinPrincipal Accounting OfficerSep 01Option Exercise3.8120,00076,20023,721Sep 03 05:00 PM
Burgess JustinPrincipal Accounting OfficerSep 01Sale20.0020,000400,0003,721Sep 03 05:00 PM
Janssen RobertSenior Vice PresidentSep 01Sale20.1590018,1358,276Sep 03 05:00 PM
Novack David FPresident & COOSep 01Sale19.9920,000399,77084,066Sep 03 05:00 PM
Hack Andrew A. F.DirectorAug 27Sale16.222,000,00032,440,0008,415,000Aug 27 08:07 PM
CANO FRANCISDirectorAug 24Option Exercise4.504,16718,75220,834Aug 25 07:32 PM
Novack David FPresident & COOAug 24Sale14.0010,000140,000104,066Aug 25 07:35 PM
Burgess JustinPrincipal Accounting OfficerAug 24Sale15.005,76886,5203,721Aug 25 07:32 PM
Novack David FPresident & COOAug 23Option Exercise4.504,16718,752114,066Aug 25 07:35 PM
Phillips Peggy VDirectorAug 23Option Exercise4.504,16618,74727,733Aug 25 07:33 PM
Janssen RobertSenior Vice PresidentAug 16Option Exercise5.422,91715,81011,193Aug 18 07:11 PM
Janssen RobertSenior Vice PresidentAug 16Sale12.362,91736,0548,276Aug 18 07:11 PM
Janssen RobertSenior Vice PresidentAug 11Option Exercise5.4249,583268,74056,444Aug 13 06:58 PM
Novack David FPresident & COOAug 11Sale12.0010,000120,000107,399Aug 13 06:59 PM
Janssen RobertSenior Vice PresidentAug 11Sale12.0649,583597,9716,861Aug 13 06:58 PM
Hack Andrew A. F.DirectorAug 09Sale10.802,250,00024,300,0008,524,000Aug 11 06:26 PM
Janssen RobertSenior Vice PresidentAug 06Sale10.7580,000860,0006,861Aug 10 06:57 PM
Novack David FPresident & COOApr 01Sale9.9220,000198,400117,399Apr 02 06:00 PM
Burgess JustinPrincipal Accounting OfficerMar 02Sale8.821,16510,2757,010Mar 02 07:52 PM
Burgess JustinPrincipal Accounting OfficerMar 01Sale8.882,95826,2678,175Mar 02 07:52 PM
Janssen RobertSenior Vice PresidentFeb 01Sale10.6442,155448,52986,485Feb 03 06:28 PM